PGNY Key Statistics, Chart & Performance
The current stock price of PGNY is 21.95 USD. In the past month the price decreased by -19.98%. In the past year, price increased by 0.14%.
PGNY Technical Analysis
PGNY Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to PGNY. PGNY scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
PGNY Financial Highlights
Over the last trailing twelve months PGNY reported a non-GAAP Earnings per Share(EPS) of 0.63. The EPS increased by 8.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.46% | ||
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| Debt/Equity | 0 |
PGNY Forecast & Estimates
17 analysts have analysed PGNY and the average price target is 30.79 USD. This implies a price increase of 40.25% is expected in the next year compared to the current price of 21.95.
For the next year, analysts expect an EPS growth of 17.75% and a revenue growth 11.37% for PGNY
PGNY Ownership
PGNY Latest News, Press Relases and Analysis
PGNY Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 15.36 | 250.601B | ||
| ELV | ELEVANCE HEALTH INC | 12.96 | 75.335B | ||
| HUM | HUMANA INC | 16.1 | 23.325B | ||
| CNC | CENTENE CORP | 12.96 | 18.904B | ||
| HQY | HEALTHEQUITY INC | 17.21 | 6.788B | ||
| MOH | MOLINA HEALTHCARE INC | 9.47 | 6.77B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | 224.46 | 4.352B | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 1.101B |
Related stock screener links
View all stocks in the Managed Health Care Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About PGNY
Company Profile
Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 675 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. The company has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The firm provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. The company provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Company Info
PROGYNY INC
1359 Broadway, 2Nd Floor
New York City NEW YORK 10018 US
CEO: David Schlanger
Employees: 675
Phone: 18009279800
PROGYNY INC / PGNY FAQ
What does PGNY do?
Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 675 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. The company has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The firm provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. The company provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Can you provide the latest stock price for PROGYNY INC?
The current stock price of PGNY is 21.95 USD. The price increased by 0.14% in the last trading session.
Does PROGYNY INC pay dividends?
PGNY does not pay a dividend.
What is the ChartMill technical and fundamental rating of PGNY stock?
PGNY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What sector and industry does PROGYNY INC belong to?
PROGYNY INC (PGNY) operates in the Health Care sector and the Health Care Providers & Services industry.
What is PROGYNY INC worth?
PROGYNY INC (PGNY) has a market capitalization of 1.89B USD. This makes PGNY a Small Cap stock.
Can you provide the short interest for PGNY stock?
The outstanding short interest for PROGYNY INC (PGNY) is 4.61% of its float.